The hypothesis that cellular proliferation leads to telomere shortening, wh
ich in turn leads to replicative failure, which in turn leads to a failure
of immune function in aged individuals, is here evaluated against the publi
shed evidence about the nature and pace of immune decline in animals and hu
mans. Although the evidence is strong that telomere shortening in late-pass
age human lymphocyte and non-lymphocytic cell lines induces a state in whic
h the cells can no longer divide, there is no compelling evidence to sugges
t that replicative senescence of this kind is an important contributor to i
mmune deficiency in old age. On the contrary, the accelerated pace of immun
e decline in mice and rats, whose telomeres are much longer than those of h
umans, argues strongly that the factors that pace age-dependent immune decl
ine do not include telomere shortening. In addition, three subsidiary argum
ents - (a) the decline with age in naive T cell proliferation despite their
relatively long telomeres; (b) the preservation of T cell proliferation in
Werner's syndrome patients despite their cell lines' proclivity to replica
tive senescence in vitro; and (c) the ability of PMA and ionomycin to stimu
late proliferation in T cells from old donors, but not in late-passage T ce
ll lines - all support the conclusion that aging of the immune system in li
ving animals is not a consequence of the kind of replicative senescence typ
ically caused by short telomeres in vitro.